Molecular basis of the immune receptor TREM2 and the generation of monoclonal antibodies against TREM2, a risk factor in Alzheimer's disease

Kim, Hyun Jung; Park, Yeon-Woo; Choi, Hee Soon; Lim, Hyun-Ho

doi:10.1016/j.ibror.2019.07.1216

Title: Molecular basis of the immune receptor TREM2 and the generation of monoclonal antibodies against TREM2, a risk factor in Alzheimer's disease

Full Record
Other Related Research

Authors:: Kim, Hyun Jung; Park, Yeon-Woo; Choi, Hee Soon; Lim, Hyun-Ho

Publication Date:: Sun Sep 01 00:00:00 EDT 2019

Sponsoring Org.:: USDOE Office of Electricity (OE), Advanced Grid Research & Development. Power Systems Engineering Research

OSTI Identifier:: 1563063

Grant/Contract Number:: HI18C1254

Resource Type:: Published Article

Journal Name:: IBRO Reports

Additional Journal Information:: Journal Name: IBRO Reports Journal Volume: 6 Journal Issue: S; Journal ID: ISSN 2451-8301

Publisher:: Elsevier

Country of Publication:: Country unknown/Code not available

Language:: English

Citation Formats


                    Kim, Hyun Jung, Park, Yeon-Woo, Choi, Hee Soon, and Lim, Hyun-Ho. Molecular basis of the immune receptor TREM2 and the generation of monoclonal antibodies against TREM2, a risk factor in Alzheimer's disease.  Country unknown/Code not available: N. p., 2019. 
Web.  doi:10.1016/j.ibror.2019.07.1216.

Copy to clipboard


                    Kim, Hyun Jung, Park, Yeon-Woo, Choi, Hee Soon, & Lim, Hyun-Ho. Molecular basis of the immune receptor TREM2 and the generation of monoclonal antibodies against TREM2, a risk factor in Alzheimer's disease.  Country unknown/Code not available.  https://doi.org/10.1016/j.ibror.2019.07.1216

Copy to clipboard


                    Kim, Hyun Jung, Park, Yeon-Woo, Choi, Hee Soon, and Lim, Hyun-Ho. Sun .  
"Molecular basis of the immune receptor TREM2 and the generation of monoclonal antibodies against TREM2, a risk factor in Alzheimer's disease".  Country unknown/Code not available.  https://doi.org/10.1016/j.ibror.2019.07.1216.

Copy to clipboard


                    
@article{osti_1563063,

  title        = {Molecular basis of the immune receptor TREM2 and the generation of monoclonal antibodies against TREM2, a risk factor in Alzheimer's disease},

  author       = {Kim, Hyun Jung and Park, Yeon-Woo and Choi, Hee Soon and Lim, Hyun-Ho},

  abstractNote = {},

  doi          = {10.1016/j.ibror.2019.07.1216},

  journal      = {IBRO Reports},

  number       = S,

  volume       = 6,

  place        = {Country unknown/Code not available},

  year         = {Sun Sep 01 00:00:00 EDT 2019},

  month        = {Sun Sep 01 00:00:00 EDT 2019}

}

Copy to clipboard

Journal Article:

Free Publicly Available Full Text

Publisher's Version of Record
https://doi.org/10.1016/j.ibror.2019.07.1216

Other availability

Search WorldCat to find libraries that may hold this journal

Save / Share:

Export Metadata

Save to My Library

Similar Records in DOE PAGES and OSTI.GOV collections:

Antibody guided diagnosis and therapy of brain gliomas using radiolabeled monoclonal antibodies against epidermal growth factor receptor and placental alkaline phosphatase

Journal Article Kalofonos, H P ; Pawlikowska, T R ; Hemingway, A ; ... - Journal of Nuclear Medicine; (USA)

Twenty-seven patients with brain glioma were scanned using {sup 123}I-labeled monoclonal antibodies against epidermal growth factor receptor (EGFR1) or placental alkaline phosphatase (H17E2). Successful localization was achieved in 18 out of 27 patients. Eleven out of 27 patients were also studied using a nonspecific control antibody (11.4.1) of the same immunoglobulin subclass and observable tumor localization was also achieved in five patients. The specificity of targeting was assessed by comparing images obtained with specific and nonspecific antibodies and by examining tumor and normal tissue biopsies after dual antibody administration. Ten patients with recurrent grade III or IV glioma who showedmore »« less
Monoclonal antibody identification of subpopulations of cerebral cortical neurons affected in Alzheimer's disease

Journal Article Miller, C A ; Rudnicka, M ; Hinton, D R ; ... - Proc. Natl. Acad. Sci. U.S.A.; (United States)

Neuronal degeneration is one of the hallmarks of Alzheimer's disease (AD). Given the paucity of molecular markers available for the identification of neuronal subtypes, the specificity of neuronal loss within the cerebral cortex has been difficult to evaluate. With a panel of four monoclonal antibodies (mAbs) applied to central nervous system tissues from AD patients, the authors have immunocytochemically identified a population of vulnerable cortical neurons; a subpopulation of pyramidal neurons is recognized by mAbs 3F12 and 44.1 in the hippocampus and neocortex, and clusters of multipolar neurons in the entorhinal cortex reactive with mAb 44.1 show selective degeneration. Closelymore »« less
https://doi.org/10.1073/pnas.84.23.8657
Development of monoclonal antibodies against parathyroid hormone: genetic control of the immune response to human PTH

Journal Article Nussbaum, S R ; Lin, C S ; Potts, Jr, J T ; ... - Methods Enzymol.; (United States)

Seventeen monocloanl antibodies against the aminoterminal portion of parathyroid hormone (PTH) were generated by using BALB/c mouse for immunization fully biologically active synthetic human PTH-(1-34) and bovine PTH-(1-84) as immunogens, monoclonal antibody methods, and a solid-phase screening assay. Isotypic analysis of these monoclonal antibodies was performed using affinity purified goat antimouse immunoglobulins specific for IgG heavy chains and ..mu..(IgM). All antibodies were IgM as evidenced by 40 times greater than background activity when 25,000 cpm of /sup 125/I-labelled goat anti-mouse IgM was used as second antibody in a radioimmunoassay.
https://doi.org/10.1016/0076-6879(85)09119-4
Monoclonal antibodies against rabbit mammary prolactin receptors. Specific antibodies to the hormone binding domain

Journal Article Katoh, M ; Djiane, J ; Kelly, P A - J. Biol. Chem.; (United States)

Three monoclonal antibodies (M110, A82, and A917) were obtained by fusing myeloma cells and spleen cells from mice immunized with partially purified rabbit mammary gland prolactin (PRL) receptors. All 3 antibodies were capable of complete inhibition of SVI-ovine prolactin (oPRL) binding to rabbit mammary PRL receptors in either particulate or soluble form. M110 showed slightly greater potency than oPRL in competing for SVI-oPRL binding. These antibodies also inhibited PRL binding to microsomal fractions from rabbit liver, kidney, adrenal, ovary, and pig mammary gland, although A82 showed poor inhibition in pig mammary gland. There was no cross-reaction of any of themore »« less
Comparison of (/sup 125/I)beta-endorphin binding to rat brain and NG108-15 cells using a monoclonal antibody directed against the opioid receptor

Journal Article Bidlack, J M ; O'Malley, W E ; Schulz, R - Mol. Pharmacol.; (United States)

The properties of (/sup 125/I)beta h-endorphin-binding sites from rat brain membranes and membranes from the NG108-15 cell line were compared using a monoclonal antibody directed against the opioid receptor and opioid peptides as probes. The binding of (/sup 125/I)beta h-endorphin to both rat brain and NG108-15 membranes yielded linear Scatchard plots with Kd values of 1.2 nM and 1.5 nM, respectively, and Bmax values of 865 fmol/mg rat brain membrane protein and 1077 fmol/mg NG108-15 membrane protein. A monoclonal antibody, OR-689.2.4, capable of inhibiting mu and delta binding but not kappa binding to rat brain membranes, noncompetitively inhibited the bindingmore »« less

Similar Records